Oak Hill Bio To Present At Upcoming Investor Conferences
Details:
The Stifel 2026 Healthcare Conference
- Format: Company presentation and one-on-one meetings Date: Thursday, November 12, 2026, at 1:20 PM ET Location: New York, NY
UBS Global Biopharma Conference 2026
- Format: Fireside chat and one-on-one meetings Date: Monday, November 16, 2026, at 4:40 PM GMT Location: London, United Kingdom
9th Annual Evercore Healthcare Conference
- Format: Fireside chat and one-on-one meetings Date: Monday, November 30, 2026, at 2:10 PM ET Location: Coral Gables, FL
Oak Hill Bio management will be available for one-on-one meetings during the conferences. Interested parties should contact their conference representative or John Fraunces (... ) to arrange a meeting.
About Oak Hill Bio
Oak Hill Bio is a clinical-stage biotechnology company focused on acquiring and developing promising therapeutics for rare diseases with significant unmet needs that have been deprioritized by pharmaceutical companies. The company's lead program is rugonersen (OHB-724), an investigational antisense oligonucleotide (ASO) in Phase 3 clinical development as a potential best-in-class treatment for Angelman syndrome, a devastating neurodevelopmental disorder with no approved disease-modifying therapies.
Oak Hill Bio is the trading name for OHB Pediatrics Ltd. It was formed in 2024 as a subsidiary of Oak Hill Bio Holdings (formerly known as Oak Hill Bio Ltd). Learn more at oakhillbio.com.
Contacts
Investors:
John Fraunces
LifeSci Advisors
...
Media:
...
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Comments
No comment